Follow
Antigen presenting cells
Antigen presenting cells (APC) are a class of immune cells that mediate the immune response. APCs process foreign antigen and present the antigen to T cells, the immune cells with kill foreign cells. Several subsets of immune cells, including dendritic cells (DC) and macrophages are capable of serving as APCs.
MAR 28, 2024 | 8:00 AM
B cell responses within pancreatic ductal adenocarcinoma (PDAC) tumors are associated with improved patient outcomes, yet the specific triggering antigens remain largely unknown. In this web...
MAR 26, 2024 | 11:00 AM
Ever wonder what you’re missing in your data? The sheer complexity of today’s flow and mass cytometry datasets demands automated solutions. Machine learning plugins only provide...
On Demand
C.E. CREDITS
Proliferation biomarkers are proteins that are up-regulated in growing cells. Immunological staining of tumor tissue can provide an indication of the aggressivity of the tumor and provide in...
NOV 07, 2023 | 10:00 AM
In the last 5 years, the US Food and Drug Administration has approved 4 anti-CD19 chimeric antigen receptor T cell (CART19) products for relapsed/refractory B cell lymphomas and leukemia. Ho...
JUL 26, 2023 | 11:20 AM
Chimeric antigen receptor (CAR)-reprogrammed immune cells offer exciting therapeutic potential for addressing oncology, autoimmune diseases, transplant medicine, and infections. However, cur...
SEP 08, 2022 | 6:00 AM
Recent outbreaks of Ebola virus (EBOV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have exposed our limited therapeutic options for such diseases and our poor understand...
SEP 08, 2022 | 6:00 AM
Since its discovery in late 2019 the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has created a global pandemic of coronavirus disease 2019 (COVID-19). As of July of 2022, mo...
JUL 21, 2022 | 8:00 AM
Date: December 09, 2022 Time: 11:00am (PST), 2:00pm (EST), 8:00pm (CEST) Flow cytometry is a trusted method to monitor T cell phenotype, plasticity, and functionality in basic research as we...
JUL 12, 2022 | 8:00 AM
Date: July 12, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CEST) Dendritic cells (DCs) are a heterogeneous population of myeloid immune cells that act as peripheral sentinels specializin...
MAY 12, 2022 | 8:00 AM
Date: May 12, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Cell culture is key for efficient and reliable T cell workflows, be it activation/ and expansion, T helper cell polarizati...
MAR 24, 2022 | 8:00 AM
Date: March 24, 2021 Time: 08:00am (PDT), 11:00pm (EDT) Simply enough, we want to treat our cells well. Afterall, we want them to tell us their stories in basic research or work for us in th...
MAR 01, 2022 | 10:00 AM
Date: March 01, 2022 Time: 10:00am (PST), 1:00pm (EST), 7:00pm (CEST) The high mortality of COVID-19 is mostly attributed to acute respiratory distress syndrome (ARDS), whose histopathologic...
FEB 23, 2022 | 6:00 AM
Cancer still accounts for nearly 1 in every 4 deaths worldwide. New immunotherapies have the power to induce durable responses in patients with fatal cancers, but only a small percentage of...
OCT 28, 2021 | 6:00 AM
Date: October 28, 2021 Time: 6:00am (PDT), 09:00am (EDT) COVID-19 has spurred the development of a plethora of tests from various manufacturers. While molecular tests and rapid antigen tests...
OCT 26, 2021 | 6:00 AM
Date: October 26, 2021 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CEST) With the IR Biotyper®, Dr. Markus Meyer will introduce the audience into the world of FT-IR (Fourier Transform Infr...
OCT 21, 2021 | 8:00 AM
DATE: October 21, 2021 TIME: 8:00am PDT Coronavirus disease 2019 (COVID-19) is a global health crisis caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and th...
OCT 13, 2021 | 12:00 AM
SARS-CoV-2 is an emergent virus. Specifically how it will adapt to human hosts and populations with growing immunity is unknown. Coronaviruses acquire substitutions more slowly than other RN...
OCT 06, 2021 | 12:00 PM
Advancements in immuno-oncology have been moving at an ever-quickening pace. From the development of new CAR-T therapies to a better understanding of the mechanism of action of monoclonal an...
